TRANSPOSON THERAPEUTICS

transposon-therapeutics-logo

Transposon Therapeutics operates as a pharmaceutical company based in Westport, Connecticut. It specializes in developing therapeutics for debilitating and life-threatening diseases

#SimilarOrganizations #People #Financial #Website #More

TRANSPOSON THERAPEUTICS

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2019-01-01

Address:
Westport, Connecticut, United States

Country:
United States

Website Url:
http://www.transposonrx.com

Total Employee:
11+

Status:
Active

Technology used in webpage:
U.S. Server Location


Similar Organizations

imagen-biotech-logo

Imagen Biotech

Imagen Biotech is focused on identifying and developing therapeutics for blinding diseases.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

modis-therapeutics-logo

Modis Therapeutics

Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.

oralome-logo

Oralome

Oralome uses cutting edge technologies and therapeutics to enable precision health.

revivo-therapeutics-logo

Revivo Therapeutics

Revivo Therapeutics is specializing in treating brain diseases.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

storemytumor-logo

StoreMyTumor

StoreMyTumor specializes in tumor preservation, advanced testing, and immune-therapy.

strykagen-logo

Strykagen

Strykagen manufactures transforming diagnostics and therapeutics for life-threatening rare muscle diseases.

tneuropharma-logo

TNeuroPharma

TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease.


Current Advisors List

bt-slingsby_image

BT Slingsby Board Member @ Transposon Therapeutics
Board_member

Current Employees Featured

dennis-podlesak_image

Dennis Podlesak
Dennis Podlesak Co-Founder & Chairman @ Transposon Therapeutics
Co-Founder & Chairman

andrew-satlin_image

Andrew Satlin
Andrew Satlin Chief Medical Officer @ Transposon Therapeutics
Chief Medical Officer

eckard-weber_image

Eckard Weber
Eckard Weber Co-Founder, Chief Executive Officer @ Transposon Therapeutics
Co-Founder, Chief Executive Officer

bt-slingsby_image

BT Slingsby
BT Slingsby Co-founder @ Transposon Therapeutics
Co-founder

Founder


bt-slingsby_image

BT Slingsby

dennis-podlesak_image

Dennis Podlesak

eckard-weber_image

Eckard Weber

Investors List

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Seed Round - Transposon Therapeutics

Official Site Inspections

http://www.transposonrx.com Semrush global rank: 2.99 M Semrush visits lastest month: 5.25 K

  • Host name: 253.24.180.107.host.secureserver.net
  • IP address: 107.180.24.253
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Transposon Therapeutics"

Transposon Therapeutics - Crunchbase Company Profile & Funding

Transposon Therapeutics operates as a pharmaceutical company based in Westport, Connecticut. It specializes in developing therapeutics for debilitating and life-threatening diseasesSee details»

Transposon Therapeutics, Inc.

Today, the only retrotransposons in our genome that are capable of becoming active are human-specific LINE-1 elements.Abnormal proteins that lead to neurodegenerative diseases, such as …See details»

Transposon 2025 Company Profile: Valuation, Funding …

Www.transposonrx.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 4660 La Jolla Village Drive; Suites 100 and 200; San Diego, CA 92122; United States +1 (858) Primary …See details»

Transposon Therapeutics - 2025 Company Profile - Tracxn

Developer of therapeutics for the treatment of neurodegenerative diseases. The company is developing TPN-101 (also known as Censavudine) and other LINE-1 reverse transcriptase …See details»

Transposon Therapeutics, Inc. | LinkedIn

Transposon Therapeutics, Inc. | 48 followers on LinkedIn. Transformational therapies for neurodegenerative and aging-related diseasesSee details»

Transposon Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...

Www.transposonrx.com. Startups | Holding Company | 2019 | Connecticut, United States | 10-50 | www.transposonrx.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational …See details»

Transposon Therapeutics, Inc. - VentureRadar

Website: https://www.transposonrx.com/ Develops innovative treatments for neurodegenerative diseases like ALS and FTD, focusing on TPN-101 to combat neurotoxic ...See details»

Transposon Therapeutics - VentureRadar

Censavudine is an orally available small molecule thymidine analogue being developed by Transposon Therapeutics under a license from Oncolys. Transposon Therapeutics was …See details»

Transposon Therapeutics | F6S

Similar companies Tune Therapeutics Sonoma Biotherapeutics PharmatrophiX, Inc Biotech company focused on developing therapeutic drugs TScan Therapeutics Retex …See details»

Transposon Therapeutics, Inc.

Our lead reverse transcriptase inhibitor, TPN-101, is the most potent known inhibitor of LINE-1 reverse transcriptase and has excellent systemic and brain bioavailability with once daily oral …See details»

Transposon Therapeutics - Canaan

Transposon Therapeutics, Inc. is developing TPN-101 (also known as Censavudine) and other LINE-1 reverse transcriptase inhibitors for the treatment of rare neurodegenerative diseases …See details»

Team - Transposon Therapeutics, Inc.

With > 30 years of experience across multiple therapeutic areas, Michael has held R&D positions at Merck and BMS prior to joining BI as Preclinical TA Head Virology and Infectious Disease …See details»

Transposon Therapeutics - Contacts, Employees, Board Members, …

Organization. Transposon Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of …See details»

Transposon Therapeutics - Products, Competitors, Financials, …

Headquarters Location. 4660 La Jolla Village Drive Suites 100 and 200. San Diego, California, 92122, United States. 858-535-4821See details»

Transposon Inc.

Contact Info 30 Kern Road Toronto, Ontario M3B 1T1, Canada Tel: 416.391.4400 Fax: 416.447.6500 [email protected]: Our vision is to enable the successful growth of …See details»

Transposon Receives US FDA Fast Track Designation for TPN-101 …

May 21, 2024 The designation of TPN-101 as a Fast Track product for PSP is supported by data from a Phase 2, randomized, double-blind, placebo-controlled study of TPN-101 in patients …See details»

Transposon to Present Results from Phase 2 Study of TPN-101 for …

Oct 15, 2024 Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of neurodegenerative and aging-related …See details»

Transposon Therapeutics-Transposon Therapeutics, Inc.-企业详情 …

查看医药魔方InvestGO®数据库Transposon Therapeutics的公司信息。Transposon Therapeutics(Transposon Therapeutics, Inc.),公司简介:Transposon is a new …See details»

Science - Transposon Therapeutics, Inc.

Today, the only retrotransposons in our genome that are capable of becoming active are human-specific LINE-1 elements.Abnormal proteins that lead to neurodegenerative diseases, such as …See details»

linkstock.net © 2022. All rights reserved